Genomics may hold the key to preventing adverse drug reactions, through a field of study alsoknown as pharmacogenomics.
Hear from three different perspectives: Colin Ross (Professor, Department of Pharmaceutical Sciences at UBC), Derek Desrosier (Director, Pharmacy Practice Support at the BC Pharmacy Association) and Amani Saini (President and Founder, Adverse Drug Reaction Canada)
A question and answer period will follow the talk.
Genome BC is proud to organize science forums at no cost but we depend on your attendance.
Please be sure you can attend before registering or contact us at firstname.lastname@example.org or call 1-604.675.1021 should you need to cancel.
Genome British Columbia leads genomics innovation on Canada's West Coast and facilitates the integration of genomics into society.
A recognized catalyst for government and industry, Genome BC invests in research, entrepreneurship and commercialization in life sciences to address challenges in key sectors such as health, forestry, fisheries, aquaculture, agri-food, energy, mining and environment.
Genome BC partners with many national and international public and private funding organizations to drive BC's bioeconomy.
400-575 West 8th Avenue Vancouver, BC V5Z 0C4 Canada [ MAP ]